INFORMATION FOR
News
View the most cited, read, and discussed research published over the summer.
A system of personalized alerts did not improve discharge prescriptions for guideline-directed medical therapy for patients hospitalized with heart failure.
PROMPT-AHF and PACT-HF tried different approaches—EHR nudges and smarter transitional care. Success proved elusive.
Tariq Ahmad, MD, MPH, will present a late-breaking clinical trial during the 2023 European Society of Cardiology Heart Failure Association annual meeting.
Yale provides cardiovascular risk assessment and treatment for patients with autoimmune diseases, including rheumatoid arthritis, systemic lupus, scleroderma, psoriatic arthritis, and vasculitis.
Groundbreaking clinical research at ACC 23.
Recent developments from the Section of Cardiovascular Medicine.
Guideline-directed medical therapies are under-utilized. Two trainees developed an interactive consult tool to provide guidance at each stage of kidney disease.
The Section of Cardiovascular Medicine published research in American Heart Journal, JAMA Internal Medicine, and JAMA Cardiology.
The Heart Failure Society of America (HFSA) Annual Scientific Meeting will take place in Washington, D.C. from September 30, 2022 to October 3, 2022.
The Pragmatic Trial of Messaging to Providers About Treatment in Heart Failure (PROMPT-HF) was designed to test the hypothesis that tailored and targeted electronic health record alerts recommending guideline-directed medical therapy (GDMT) for patients with heart failure (HF) would result in greater adherence to medication use.
An embedded electronic health record algorithm that provided HF mortality risk information did not affect clinical decision making about initiation or intensity of treatment or improve outcomes in adults with HF, data show.
Late-Breaking Basic Science submissions for the AHA Scientific Sessions close August 23.
No significant differences in targeted interventions occurred between patients with heart failure managed by clinicians with additional prognostic information compared to those without.
Nihar R. Desai, MD, discusses data from the GALACTIC-HF study.
“Computer” popups developed at Yale are improving medical care for patients. Results from a new story show that pop-up alerts embedded into the electronic health records of certain heart failure patients allowed physicians to prescribe more guideline directed medications.
Physicians treating patients with heart failure and reduced ejection fraction (HFrEF) were more likely to prescribe an added drug class, out of the four guideline-directed medical therapy (GDMT) classes, when they were prompted by an alert in a patient's electronic health record (EHR).
A personalized alert triggered via the electronic health record during office visits resulted in more frequent prescription of guideline-directed medical therapies for patients with HF with reduced ejection fraction.
Data from PROMPT-HF show clinicians are more likely to add 1 of 4 topline drug classes to a patient's HFrEF regimen when alerted on the opportunity.
The simple, personalized alerts embedded in EHRs led to increases in the number of GDMT classes prescribed.